February 14, 2017 / 12:18 PM / 8 months ago

BRIEF-Axsome Therapeutics receives FDA fast track designation for AXS-05

Feb 14 (Reuters) - Axsome Therapeutics Inc :

* Axsome Therapeutics receives FDA fast track designation for AXS-05 for treatment resistant depression Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below